{
    "info": {
        "nct_id": "NCT06103838",
        "official_title": "A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma",
        "inclusion_criteria": "* INCLUSION CRITERIA:\n* Participants must have a documented diagnosis of MM defined by the IMWG Criteria. Participants at diagnosis must have had a serum M-protein >= 3 g/dL and/or bone marrow plasma cells >= 10% and at least one of the following:\n\n  * Anemia: Hemoglobin <=10 g/dL, or\n  * Renal Failure: serum creatinine >= 2.0 mg/dL, or\n  * Hypercalcemia: Ca >= 10.5 mg/dL, or\n  * Lytic bone lesions on X-ray, CT, or PET/CT, or\n  * >= 2 focal lesions on spinal MRI, or\n  * >= 60% bone marrow plasma cells, or\n  * Involved/un-involved serum free light chain ration >= 100\n* Participants must have measurable disease defined by any one of the following:\n\n  * Monoclonal bone marrow plasma cells > 5%\n  * Serum monoclonal protein >= 0.2 g/dl\n  * Urine monoclonal protein > 200 mg/24 hr\n  * Serum immunoglobulin free light chain > 10 mg/dL AND abnormal kappa/lambda ratio\n  * A measurable lesion on PET/CT or MRI\n* Participants fit criteria for one of the following categories:\n\n  * Newly diagnosed multiple myeloma (NDMM)\n  * Relapsed and/or refractory multiple myeloma (RRMM) with at least 1 prior line of therapy\n* Age >=18 years.\n* ECOG performance status <= 2\n* Negative serum or urine pregnancy test at screening for WOCBP.\n* Women of child-bearing potential and men must agree to use effective contraception (hormonal or barrier method of birth control; abstinence) 24 hours prior to and for the 24 hours after each 18F-fluciclovine administration.\n* Ability of subject to understand and the willingness to sign a written informed consent document.\n\nEXCLUSION CRITERIA:\n\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to 18F-FDG\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to 18F-fluciclovine or other similar agents.\n* Subjects with severe claustrophobia unresponsive to oral anxiolytics or unwilling to take them.\n* Uncontrolled intercurrent illness including, psychiatric illness/social situations that would limit compliance with study requirements.\n* Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with 18F-fluciclovine, breastfeeding should be discontinued if the mother is treated with 18F-fluciclovine until 3 days after 18F-fluciclovine.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 120 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have maximum age of 120 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 120 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 120,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Anemia: Hemoglobin <=10 g/dL, or",
            "criterions": [
                {
                    "exact_snippets": "Anemia: Hemoglobin <=10 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 10,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Involved/un-involved serum free light chain ration >= 100",
            "criterions": [
                {
                    "exact_snippets": "Involved/un-involved serum free light chain ration >= 100",
                    "criterion": "serum free light chain ratio (involved/un-involved)",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability of subject to understand and the willingness to sign a written informed consent document.",
            "criterions": [
                {
                    "exact_snippets": "Ability of subject to understand",
                    "criterion": "subject's ability to understand",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent document",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A measurable lesion on PET/CT or MRI",
            "criterions": [
                {
                    "exact_snippets": "A measurable lesion on PET/CT or MRI",
                    "criterion": "lesion",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "PET/CT",
                                "MRI"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status <= 2",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status <= 2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Negative serum or urine pregnancy test at screening for WOCBP.",
            "criterions": [
                {
                    "exact_snippets": "Negative serum or urine pregnancy test at screening",
                    "criterion": "pregnancy test result",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "for WOCBP",
                    "criterion": "women of childbearing potential status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Lytic bone lesions on X-ray, CT, or PET/CT, or",
            "criterions": [
                {
                    "exact_snippets": "Lytic bone lesions on X-ray, CT, or PET/CT",
                    "criterion": "lytic bone lesions",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "X-ray",
                                "CT",
                                "PET/CT"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum immunoglobulin free light chain > 10 mg/dL AND abnormal kappa/lambda ratio",
            "criterions": [
                {
                    "exact_snippets": "Serum immunoglobulin free light chain > 10 mg/dL",
                    "criterion": "serum immunoglobulin free light chain",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "mg/dL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "abnormal kappa/lambda ratio",
                    "criterion": "kappa/lambda ratio",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "abnormal"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women of child-bearing potential and men must agree to use effective contraception (hormonal or barrier method of birth control; abstinence) 24 hours prior to and for the 24 hours after each 18F-fluciclovine administration.",
            "criterions": [
                {
                    "exact_snippets": "Women of child-bearing potential and men must agree to use effective contraception (hormonal or barrier method of birth control; abstinence) 24 hours prior to and for the 24 hours after each 18F-fluciclovine administration.",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "method",
                            "expected_value": [
                                "hormonal",
                                "barrier method of birth control",
                                "abstinence"
                            ]
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "24 hours prior to and for the 24 hours after each 18F-fluciclovine administration"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum monoclonal protein >= 0.2 g/dl",
            "criterions": [
                {
                    "exact_snippets": "Serum monoclonal protein >= 0.2 g/dl",
                    "criterion": "serum monoclonal protein",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0.2,
                                "unit": "g/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with 18F-fluciclovine, breastfeeding should be discontinued if the mother is treated with 18F-fluciclovine until 3 days after 18F-fluciclovine.",
            "criterions": [
                {
                    "exact_snippets": "breastfeeding should be discontinued if the mother is treated with 18F-fluciclovine until 3 days after 18F-fluciclovine",
                    "criterion": "breastfeeding",
                    "requirements": [
                        {
                            "requirement_type": "discontinuation period after 18F-fluciclovine treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* >= 60% bone marrow plasma cells, or",
            "criterions": [
                {
                    "exact_snippets": ">= 60% bone marrow plasma cells",
                    "criterion": "bone marrow plasma cells",
                    "requirements": [
                        {
                            "requirement_type": "percentage",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* >= 2 focal lesions on spinal MRI, or",
            "criterions": [
                {
                    "exact_snippets": ">= 2 focal lesions on spinal MRI",
                    "criterion": "focal lesions on spinal MRI",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "lesions"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Monoclonal bone marrow plasma cells > 5%",
            "criterions": [
                {
                    "exact_snippets": "Monoclonal bone marrow plasma cells > 5%",
                    "criterion": "monoclonal bone marrow plasma cells",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants must have a documented diagnosis of MM defined by the IMWG Criteria. Participants at diagnosis must have had a serum M-protein >= 3 g/dL and/or bone marrow plasma cells >= 10% and at least one of the following:",
            "criterions": [
                {
                    "exact_snippets": "documented diagnosis of MM defined by the IMWG Criteria",
                    "criterion": "multiple myeloma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": "multiple myeloma as defined by IMWG Criteria"
                        }
                    ]
                },
                {
                    "exact_snippets": "at diagnosis must have had a serum M-protein >= 3 g/dL",
                    "criterion": "serum M-protein",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "g/dL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "bone marrow plasma cells >= 10%",
                    "criterion": "bone marrow plasma cells",
                    "requirements": [
                        {
                            "requirement_type": "percentage",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with severe claustrophobia unresponsive to oral anxiolytics or unwilling to take them.",
            "criterions": [
                {
                    "exact_snippets": "severe claustrophobia",
                    "criterion": "claustrophobia",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    ]
                },
                {
                    "exact_snippets": "unresponsive to oral anxiolytics",
                    "criterion": "response to oral anxiolytics",
                    "requirements": [
                        {
                            "requirement_type": "responsiveness",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "unwilling to take them",
                    "criterion": "willingness to take oral anxiolytics",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hypercalcemia: Ca >= 10.5 mg/dL, or",
            "criterions": [
                {
                    "exact_snippets": "Hypercalcemia: Ca >= 10.5 mg/dL",
                    "criterion": "serum calcium level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10.5,
                                "unit": "mg/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Newly diagnosed multiple myeloma (NDMM)",
            "criterions": [
                {
                    "exact_snippets": "Newly diagnosed multiple myeloma (NDMM)",
                    "criterion": "multiple myeloma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis status",
                            "expected_value": "newly diagnosed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants must have measurable disease defined by any one of the following:",
            "criterions": [
                {
                    "exact_snippets": "Participants must have measurable disease",
                    "criterion": "disease",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Renal Failure: serum creatinine >= 2.0 mg/dL, or",
            "criterions": [
                {
                    "exact_snippets": "Renal Failure: serum creatinine >= 2.0 mg/dL",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2.0,
                                "unit": "mg/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants fit criteria for one of the following categories:",
            "criterions": [
                {
                    "exact_snippets": "Participants fit criteria for one of the following categories",
                    "criterion": "category membership",
                    "requirements": [
                        {
                            "requirement_type": "membership",
                            "expected_value": "one of the following categories"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of allergic reactions attributed to compounds of similar chemical or biologic composition to 18F-fluciclovine or other similar agents.",
            "criterions": [
                {
                    "exact_snippets": "History of allergic reactions attributed to compounds of similar chemical or biologic composition to 18F-fluciclovine or other similar agents.",
                    "criterion": "allergic reactions to compounds of similar chemical or biologic composition to 18F-fluciclovine or other similar agents",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Relapsed and/or refractory multiple myeloma (RRMM) with at least 1 prior line of therapy",
            "criterions": [
                {
                    "exact_snippets": "Relapsed and/or refractory multiple myeloma (RRMM)",
                    "criterion": "multiple myeloma",
                    "requirements": [
                        {
                            "requirement_type": "disease status",
                            "expected_value": [
                                "relapsed",
                                "refractory"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "at least 1 prior line of therapy",
                    "criterion": "prior lines of therapy",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lines"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age >=18 years.",
            "criterions": [
                {
                    "exact_snippets": "Age >=18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled intercurrent illness including, psychiatric illness/social situations that would limit compliance with study requirements.",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled intercurrent illness",
                    "criterion": "intercurrent illness",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness/social situations that would limit compliance with study requirements",
                    "criterion": "psychiatric illness or social situations",
                    "requirements": [
                        {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Urine monoclonal protein > 200 mg/24 hr",
            "criterions": [
                {
                    "exact_snippets": "Urine monoclonal protein > 200 mg/24 hr",
                    "criterion": "urine monoclonal protein",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 200,
                                "unit": "mg/24 hr"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of allergic reactions attributed to compounds of similar chemical or biologic composition to 18F-FDG",
            "criterions": [
                {
                    "exact_snippets": "History of allergic reactions attributed to compounds of similar chemical or biologic composition to 18F-FDG",
                    "criterion": "allergic reactions to compounds of similar chemical or biologic composition to 18F-FDG",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "* INCLUSION CRITERIA:",
            "criterions": []
        },
        {
            "line": "EXCLUSION CRITERIA:",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}